Influence of Isoflurane inhalative sedation on the validation of liver function using liver maximum capacity (LiMAx®)-Test

Influence of Isoflurane inhalative sedation on the validation of liver function using liver maximum capacity (LiMAx®)-Test - LimaxIso

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022228

Enrollment

Registered

2020-09-17

Start date

2020-09-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K72.0

Interventions

Group 1: Liver function capacity measurement at timepoints T0: under sedation with Propofol, T1: under sedation with Isoflurane T2: min. 24h after T1, T3: after sedation

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Intensiv care patients sedatedwith Propofol/ Isoflurane.

Exclusion criteria

Exclusion criteria: Pregnancy

Design outcomes

Primary

Measure	Time frame
Correlation of the LiMAx value measured during sedation with Propofol/Isoflurane with standard laboratory parameters related to liver function.	—

Secondary

Measure	Time frame
Correlation of the LiMAx value measured during sedation with Propofol/Isoflurane with further standard laboratory parameters.	—

Countries

Germany

Contacts

Public ContactDietrich Henzler

Universitätsklinik für Anästhesiologie, operative Intensivmedizin, Rettungsmedizin, Schmerztherapie, Campus OWL, Klinikum Herford AöR

dietrich.henzler@klinikum-herford.de+49 (0)5221 94 2481

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026